Combined treatment with systemic resveratrol and resveratrol preconditioned mesenchymal stem cells, maximizes antifibrotic action in diabetic cardiomyopathy. [electronic resource]
Producer: 20200520Description: 10942-10963 p. digitalISSN:- 1097-4652
- Animals
- Antioxidants -- therapeutic use
- Bone Malalignment
- Diabetes Mellitus, Experimental -- complications
- Diabetic Cardiomyopathies -- therapy
- Fibrosis -- therapy
- Male
- Mesenchymal Stem Cell Transplantation
- Mesenchymal Stem Cells -- drug effects
- Random Allocation
- Rats
- Rats, Wistar
- Resveratrol -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.